Abstract 1652
Background
In cancer patients undergoing myelosuppressive chemotherapy, granulocyte colony-stimulating factor (G-CSF) reduces the risk of neutropenic complications and decreases need for dose reductions,1 allowing potential improvement of survival. A recent meta-analysis found that those receiving G-CSF have significantly improved overall survival (OS) versus those who do not.2 Deemed a “gold standard” approach for estimating probabilities of survival for time-to-event data,3 Kaplan-Meier (KM) estimates are a non-parametric method with no underlying distributional assumptions, allowing comparison between studies. Meta-analysis methods based on KM curves have been proposed.4,5 We present a new approach of pooling KM curves, improving their accuracy in assessing survival probabilities.
Methods
Our new approach pinpoints specific coordinates on KM curves using web-based digital graphics data extraction tools. When the amount of at risk patients during a specific time period is known, the number of patients experiencing events can be calculated, or if unknown, imputed by “borrowing” event percentages from a study with a similar KM survival profile. Using minimum squared distances between pairs, the similarity between two KM curves can be determined. Reconstructed event times can be used for meta-analyses, using fixed or random effect modeling with weights for each study.
Results
This approach was applied to 70 reports of OS in cancer patients receiving chemotherapy with or without G-CSF prophylaxis, including recent meta-analysis data.2 Preliminary results are in line with published data. Supporting reports of better survival in patients receiving G-CSF, the new approach provides synthesized KM curves, allowing comparisons of survival probabilities between treatments at any given time points.
Conclusions
Our preliminary results support findings of significantly improved OS in cancer patients receiving G-CSF. References: 1. Aapro et al. Support Care Cancer 2010;18:529–41. 2. Lyman et al. Blood 2017:130;3424. 3. Land et al. Procedia Comput Sci. 2011;6:267–72. 4. Parmar et al. Statist Med. 1998; 17:2815–34. 5. Tierney et al. Trials 2007;8:16.
Clinical trial identification
Legal entity responsible for the study
Hexal AG, Holzkirchen, Germany.
Funding
Hexal AG, Holzkirchen, Germany.
Editorial Acknowledgement
Terri Penfold, Spirit Medical Communications.
Disclosure
A. Krendyukov, L. Yau: Employee: Hexal AG.
Resources from the same session
2069 - The concordance with antiemetic guideline for pediatric, adolescent and young adult patients with cancer using a large-scale administrative database.
Presenter: Seiko Bun
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
2740 - Effectiveness of surgical glove compression therapy as a prophylactic method against nab-Paclitaxel induced peripheral neuropathy
Presenter: Shigeru Tsuyuki
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
2229 - Effect of oral magnesium supplementation on the kinetics of magnesium wasting induced by EGFR targeted antibody therapy for colorectal carcinoma (MAGNET trial)
Presenter: Hubert Piessevaux
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
4155 - Pilot and definitive randomised double-blind placebo-controlled trials evaluating an oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting (CINV)
Presenter: Antony Mersiades
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
2473 - Pregnancies after breast cancer, is there a real need for fertility preservation ? Results from the ARTEMIS cohort of 60 young patients
Presenter: Jerome Martin-Babau
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
3450 - Inclusion of adolescents in adult early phase trials and young adults in paediatric early phase trials: a reality or a myth?
Presenter: Aurore Vozy
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
2917 - Indicators of non-uptake of breast cancer screening: results from the EDIFICE 6 survey
Presenter: Jean-Francois Morere
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
2920 - Benefits of physical activity and sport integrated into the care pathway of oncology patient
Presenter: Laurence Vanlemmens
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
5334 - Identifying barriers to physical activity in patients with lung cancer: an Australian pilot study
Presenter: Quan Tran
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
6108 - Quality of life, late effects, and related clinical factors among Korean colorectal cancer survivors
Presenter: Ji Soo Park
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract